These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6345959)

  • 1. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties.
    de Souza NJ; Dohadwalla AN; Reden J
    Med Res Rev; 1983; 3(2):201-19. PubMed ID: 6345959
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology and inotropic potential of forskolin in the human heart.
    Bristow MR; Ginsburg R; Strosberg A; Montgomery W; Minobe W
    J Clin Invest; 1984 Jul; 74(1):212-23. PubMed ID: 6330174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihypertensive and positive inotropic diterpene forskolin: effects of structural modifications on its activity.
    Bhat SV; Dohadwalla AN; Bajwa BS; Dadkar NK; Dornauer H; de Souza NJ
    J Med Chem; 1983 Apr; 26(4):486-92. PubMed ID: 6682146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of renal adenylate cyclase by forskolin: assessment of enzymatic activity in animal models of the secondary hyperparathyroid state.
    Forte LR
    Arch Biochem Biophys; 1983 Sep; 225(2):898-905. PubMed ID: 6312897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin as a probe of adenylate cyclase of adipocytes.
    Ho RJ; Shi QH
    Mol Cell Endocrinol; 1983 Jun; 30(3):279-90. PubMed ID: 6683205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanosine 5'-(beta, gamma-imido)triphosphate inhibition of forskolin-activated adenylate cyclase is mediated by the putative inhibitory guanine nucleotide regulatory protein.
    Seamon KB; Daly JW
    J Biol Chem; 1982 Oct; 257(19):11591-6. PubMed ID: 6288693
    [No Abstract]   [Full Text] [Related]  

  • 7. Forskolin potentiates the coronary vasoactivity of adenosine in the open-chest dog.
    Kusachi S; Bugni WJ; Olsson RA
    Circ Res; 1984 Jul; 55(1):116-9. PubMed ID: 6086169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive inotropic-acting forskolin, a potent adenylate cyclase activator.
    Metzger H; Lindner E
    Arzneimittelforschung; 1981; 31(8):1248-50. PubMed ID: 7197529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forskolin requires more than the catalytic unit to activate adenylate cyclase.
    Stengel D; Guenet L; Desmier M; Insel P; Hanoune J
    Mol Cell Endocrinol; 1982; 28(3):681-90. PubMed ID: 6891346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of adenylate cyclase of human platelet membranes by forskolin.
    Insel PA; Stengel D; Ferry N; Hanoune J
    J Biol Chem; 1982 Jul; 257(13):7485-90. PubMed ID: 7045106
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of action of forskolin on adenylate cyclase: effect on bovine sperm complemented with erythrocyte membranes.
    Schneyer CR; Piñeyro MA; Gregerman RI
    Life Sci; 1983 Jul; 33(3):275-9. PubMed ID: 6683352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forskolin (a powerful inhibitor of human platelet aggregation).
    Adnot S; Desmier M; Ferry N; Hanoune J; Sevenet T
    Biochem Pharmacol; 1982 Dec; 31(24):4071-4. PubMed ID: 6818975
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of forskolin-stimulated cardiac adenylate cyclase activity by short-chain alcohols.
    Robberecht P; Waelbroeck M; Chatelain P; Camus JC; Christophe J
    FEBS Lett; 1983 Apr; 154(1):205-8. PubMed ID: 6682050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative.
    Hosono M; Takahira T; Fujita A; Fujihara R; Ishizuka O; Tatee T; Nakamura K
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):625-34. PubMed ID: 1380607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered hormone sensitivity of adenylate cyclase in myocardial sarcolemma of renal hypertensive rats.
    Anand-Srivastava MB; Cantin M; Genest J
    Biochem Pharmacol; 1983 Oct; 32(19):2857-62. PubMed ID: 6684927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kinetic analysis of activation of smooth muscle adenylate cyclase by forskolin.
    Krall JF
    Arch Biochem Biophys; 1984 Mar; 229(2):492-7. PubMed ID: 6538401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation.
    Burka JF; Saad MH
    Br J Pharmacol; 1984 Nov; 83(3):645-55. PubMed ID: 6439271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and adenylate cyclase stimulating effects of colforsin daropate, a water-soluble forskolin derivative, compared with those of isoproterenol, dopamine and dobutamine.
    Yoneyama M; Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Hashimoto K
    Circ J; 2002 Dec; 66(12):1150-4. PubMed ID: 12499623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.
    Robberecht P; De Neef P; Waelbroeck M; Camus JC; Fontaine J; Christophe J
    Pflugers Arch; 1984 May; 401(1):1-5. PubMed ID: 6540864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forskolin inhibits tension development in detergent-treated cardiac muscle fibers.
    Pfitzer G; Rüegg JC
    Experientia; 1984 Jan; 40(1):65-7. PubMed ID: 6198201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.